Author Archives: research

About research

Philstocks.ph™ is the online trading division of Accord Capital Equities Corporation (ACEC). In line with its mission to develop the latest innovations and technologies for efficient trade executions of clients, Accord Capital has created the Philstocks.ph™ in 2006 to become an effective online trading platform. In retrospect, not all brokerage houses have an online trading platform. In fact, there are only 10 PSE-recognized online trading facilities to date. This makes Philstocks.ph™ a member of an elite club of online trading participants.

On Balance: Daily Notes for February 16, 2021

Posted on February 15, 2021 by research

OUR VIEW Trade within the market’s short-term range of 6,800 to 7,100 as investors weighed the further reopening of the economy and the risk of the new Covid-19 variant in the Philippines. Investors are also waiting for the full year … Continue reading →

Comments Off

On Balance: Weekly Notes for February 15, 2021

Posted on February 15, 2021 by research

OUR VIEW FOR THE WEEK Unload positions this week as we see a downward bias for the local market on the back of inflation worries and COVID-19 concerns. The expectation that inflation would remain elevated moving forward may weigh on … Continue reading →

Comments Off

Philstocks 2020 Review & 2021 Outlook

Posted on February 11, 2021 by research

We are pleased to share with you our 2020 Review and 2021 Outlook for the Economy and the Philippine Stock Market entitled “Hope Amid the Pressing Times”. Revisit what happened to our economy and our local market this past 2020. … Continue reading →

Comments Off

On Balance: Daily Notes for February 11, 2021

Posted on February 10, 2021 by research

OUR VIEW Book some gains after the market rally for five consecutive days since it invites profit taking which is intensified by the long weekend ahead. We are also expecting investors to wait for the outlook of the Bangko Sentral … Continue reading →

Comments Off

On Balance: Daily Notes for February 10, 2021

Posted on February 9, 2021 by research

OUR VIEW Accumulate more shares amid the developments on the Covid-19 vaccine with the expectation of a rollout in the coming week which is anticipated to spur more optimism in the local bourse. But still, be cautious as the market … Continue reading →

Comments Off

On Balance: Daily Notes for February 09, 2021

Posted on February 8, 2021 by research

OUR VIEW Trade stocks outside the PSEi as investors may profit take after three consecutive days of gains. Investors are also waiting for the outlook and decision of the Bangko Sentral ng Pilipinas (BSP) on inflation rate after the Philippines … Continue reading →

Comments Off

On Balance: Trading Guide for February 08 to 11, 2021

Posted on February 8, 2021 by research

Philstocks Trading Guide We are glad to share this Philstocks Trading Guide to help you widen your trading opportunities and become a more effective stock market trader. Stocks on focus: MM & IRC For the full research,  kindly go here: Philstocks Trading Guide … Continue reading →

Comments Off

On Balance: Daily Notes for February 05, 2021

Posted on February 4, 2021 by research

OUR VIEW Book some gains if the market declines below 6,900 amid the release of the January inflation rate. This is expected to spill negative sentiment in the market due to the increase of food prices that lowers consumers’ purchasing … Continue reading →

Comments Off

On Balance: Daily Notes for February 04, 2021

Posted on February 3, 2021 by research

OUR VIEW Trade cautiously ahead of the release of the January inflation rate. The expected quicker inflation rate may drag sentiment as it lowers the purchasing power of consumers which is negatively affecting the overall consumption. Chart-wise, immediate support is … Continue reading →

Comments Off

On Balance: Daily Notes for February 03, 2021

Posted on February 2, 2021 by research

OUR VIEW Take positions amid positive sentiment over the Covid-19 vaccine development. At home, it is expected to get Covid-19 doses from Pfizer-BioNtech and AstraZeneca within the first quarter of 2021. In Europe, economic recovery hopes spur a bullish outlook … Continue reading →

Comments Off